Pretreatment hematocrit as an independent prognostic variable in Hodgkin's disease.
Blood
; 68(2): 562-4, 1986 Aug.
Article
en En
| MEDLINE
| ID: mdl-3730617
Pretreatment hematocrit in 117 advanced-stage Hodgkin's disease patients treated with a combined modality therapy program was evaluated as an independent prognostic variable with regard to survival and relapse-free survival. Age greater than 40 years, and multiple extranodal sites of involvement were found to be statistically significant independent negative prognostic factors with regard to survival. Pretreatment hematocrit, however, was not an independent negative prognostic variable.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedad de Hodgkin
/
Hematócrito
Tipo de estudio:
Prognostic_studies
Límite:
Adult
/
Humans
/
Middle aged
Idioma:
En
Revista:
Blood
Año:
1986
Tipo del documento:
Article
Pais de publicación:
Estados Unidos